CNP blocks mitochondrial depolarization and inhibits SARS-CoV-2 replication in vitro and in vivo
J. Logue, V. Melville, J. Ardanuy, M. Frieman
This paper identifies CNP as a novel antiviral target that inhibits SARS-CoV-2 replication by blocking mitochondrial depolarization and mPTP activation in vitro and in vivo.
bioRxiv · Jun 9, 2023Microbiology